Positron Emission Tomography Market report gives attention to market segmentation, market size, and forecast of 2023-2032 to help stakeholders in making a good decision for the future investments. Urinary Catheters industry report segmented into types, application, and regions with providing production, revenue, import/export.
According to the latest research report by IMARC Group, The global positron emission tomography market size reached US$ 1,084 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,512 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028. More Info:- https://www.imarcgroup.com/positron-emission-tomography-market
Positron Emission Tomography Scanners market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Positron Emission Tomography Scanners market will be able to gain the upper hand as they use the report as a powerful resource.
Avail more information from Sample Brochure of report @ http://bit.ly/2C3wEaY A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Global Positron Emission Tomography Imaging Market and future opportunities are provided in the report.
Looking forward, the positron emission tomography (PET) market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/positron-emission-tomography-market
General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., Siemens AG, Hitachi, Ltd., Positron Corporation, Mediso Ltd., and Yangzhou Kindsway Biotech Co. Ltd. are some of the leading players operating in the global Positron Emission Tomography (PET) scanners market.
Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies. Request for a sample copy of the ‘Positron Emission Tomography’ Market report@: https://www.globalmarketestimates.com/positron-emission-tomography-market/
Looking forward, the positron emission tomography market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/positron-emission-tomography-market
PET is most widely used by oncologists in order to diagnose various types of cancer; neurologists in order to diagnose neurological disorders and cardiologists in order to diagnose cardiovascular diseases.
“Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2016" provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.
Global Image Guided Surgery Devices Market is estimated to reach $5.4 billion by 2024; growing at a CAGR of 6.4% from 2016 to 2024. Image guided surgery devices, also known as surgical navigation devices, are used in any surgical procedure by providing accurate treatment guidance and ensure safety of vital structures.
Fueled by the growing focus on patient safety and technological advancements, the healthcare/medical simulation industry has experienced significant growth over the past decade, except for the past 3 to 4 years, where the market witnessed slow growth due to the global recession.
Big Market Research : Global Small Animal Imaging (In-Vivo) Market (Technology, Applications and Geography): Research, Report, Opportunities, Segmentation and Forecast 2020 To Get More Details @ http://www.bigmarketresearch.com/small-animal-imaging-market Imaging modalities emerged as a preferred option for the clinical industry, especially in preclinical studies. Many of the imaging technologies have been translated into micro level tools that include micro MRI, micro CT and micro PET.
"India Nuclear Imaging Equipment Market Outlook to 2022", provides key market data on the India Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Single Photon Emission Computed Tomography (SPECT) Systems, Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems and Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems. http://www.marketreportsonindia.com/life-sciences-market-research-reports-3211/india-nuclear-imaging-equipment.html
Global Brain And Neuroimaging Devices Market by The Business Research Company is segmented as Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalograph https://bit.ly/3p4fLaz
the purpose of study global medical imaging equipment market is studied on the basis of type of product such as X-ray devices (stationary and portable X-ray devices), ultrasound systems (cart/trolley based and compact/portable ultrasound systems), computed tomography (CT) scanners (stationary and portable CT scanner), magnetic resonance imaging (MRI) equipment (closed and open MRI equipment) and nuclear imaging equipment (Single Photon Emission Computed Tomography, Scanners and Positron Emission Tomography Scanners). On the other hand, on the basis of technology market is categorized as X-ray technology (Analog X-ray technology,
the forecast period 2020 to 2027. On the basis of segmentation, the global brain health devices market is majorly segmented by product type into computed tomography (CT), electroencephalogram (EEG), magnetoencephalogram (MEG), magnetic resonance imaging (MRI), intracranial pressure (ICP) monitors , transcranial doppler (TCD) devices, , cerebral oximeters and Others (positron emission tomography (PET) devices, sleep monitoring devices, electromyography (EMG) device). On the basis of therapeutic applications, the global brain health devices market majorly include dementia,
Global Parkinson’s Disease Therapeutics Market Information by Diagnostics Test (Positron Emission Topography (PET) Scan, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)) By Drugs (Sinemet, Dopamine Agonists, Symmetrel, Anticholinergics, Eldepryl And Azilect, COMT and Others) - Forecast to 2022
Global Parkinson’s Disease Therapeutics Market Information by Diagnostics Test (Positron Emission Topography (PET) Scan, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)) By Drugs (Sinemet, Dopamine Agonists, Symmetrel, Anticholinergics, Eldepryl And Azilect, COMT and Others) - Forecast to 2022
Automated Radiosynthesis modules drive the production of radiotracer for PET and SPECT (Single-Photon Emission Computed Tomography) imaging in decentralized settings. These modules are user friendly, simple to set up, and offer scope of customized formulations of radiotracer for diagnostic and therapy administration, and hence their adoption will be increasing in near future. Automated Radiosynthesis Modules Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $32 million by 2022, registering a CAGR of 6.6% during the period 2016 - 2022.North America accounted for the largest share in terms of both market revenues and unit volumes, whereas Asia-Pacific region is expected to witness fastest growth rate during the forecast period. Read Full Report here: https://www.alliedmarketresearch.com/automated-radio-synthesis-modules-market Download Sample report @ https://www.alliedmarketresearch.com/request-free-sample/1761
The Soft Tissue Sarcoma market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Soft Tissue Sarcoma market.
Cancer Biomarkers Market Information Type (Genetic Biomarkers, Epigenetic Biomarkers, Proteomic Biomarkers, Glycoprotein Biomarkers), Disease Type, Profiling Technologies and Application: Forecast To 2027
According to the latest research report by IMARC Group, The global image-guided therapy systems market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. More Info:- https://www.imarcgroup.com/image-guided-therapy-systems-market
The clinical trial imaging market size is expected to reach US$ 2,480.32 million by 2028 from US$ 1,610.70 million in 2022; it is estimated to record a CAGR of 7.6% from 2023 to 2028.
Cancer Biomarkers Market Information By Type (Genetic Biomarkers, Epigenetic Biomarkers, Proteomic Biomarkers, Glycoprotein Biomarkers), Disease Type, Profiling Technologies and Application: Forecast To 2027
Global Medical Devices Market is expected to grow at CAGR of 5.4% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Medical Devices Market. The market sizing is provided
Future Market Insights delivers key insights and presents a revised forecast of the global aortic stent grafts market for a 10-year period from 2018 to 2028 in the report titled “Aortic Stent Grafts Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028.” The revision in the market size and volume forecasts has been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of the key market participants. In terms of revenue, the global aortic stent grafts market is projected to expand at a 7.6% CAGR over the forecast period of 2018-2028.
According to the latest research report by IMARC Group, The global neurotechnology market size reached US$ 11.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.2 Billion by 2032, exhibiting a growth rate (CAGR) of 10.54% during 2024-2032. More Info:- https://www.imarcgroup.com/neurotechnology-market
The global radiopharmaceuticals market was worth USD 4.31 Billion in 2020 and is further projected to reach USD 6.43 Billion by 2027, at a CAGR of 6.0% during 2021-2027 (forecast period).
The global image-guided surgery devices market is estimated to garner a revenue of ~USD 8 billion by the end of 2031 by growing at a CAGR of ~7% over the forecast period, i.e., 2022 – 2031.
According to the National Brain Tumour Society, an estimated 688,000 plus people are living with a primary brain or Central Nervous System (CNS) tumor. Brain tumors generally occur in supportive brain tissues. The exact cause of brain tumor is not yet known, and it can occur in any age group. A brain tumor is an abnormal and uncontrolled proliferation of cells in the brain. It can be benign or malignant. Brain tumor arises from brain tissue and rarely spreads. The tumor eventually compress and damage other structures in the brain.
Clinical trial imaging is a component of massive research and development of biotechnology and pharmaceutical industries and drug development process. It helps in making trial more effective and accurate.
Global Image Guided Surgery Devices Market is estimated to reach $5.4 billion by 2024; growing at a CAGR of 6.4% from 2016 to 2024. Image guided surgery devices, also known as surgical navigation devices, are used in any surgical procedure by providing accurate treatment guidance and ensure safety of vital structures.
According to the latest research report by IMARC Group, The global nuclear medicine equipment market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.65% during 2023-2028. More Info:- https://www.imarcgroup.com/nuclear-medicine-equipment-market
The global metastatic Castration-Resistant Prostate Cancer market is expected to register a robust revenue CAGR over the forecast period owing to increased cases of prostate cancer. For instance, prostate cancer is the second most frequent cancer in males and fourth most prevalent cancer in general population.
Gastric cancer testing market, size, share, market intelligence, company profiles, market trends, strategy, analysis, forecast 2017-2022 STOMACH CANCER MARKET INSIGHTS The Stomach cancer market is expected to grow at a modest CAGR of 5.8% during 2017-2022. Growing elderly population, technological advancement and rising incidence and prevalence rate of gastric cancer are boosting the stomach cancer market across the globe. Gastric cancer leads to uncontrolled progress of malignant cells that originate in stomach tissue.
According to the latest research report by IMARC Group, The global lymphoma treatment market size reached US$ 12.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 20.1 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028. More Info:- https://www.imarcgroup.com/lymphoma-treatment-market
According to the latest research report by IMARC Group, The global gold nanoparticles market size reached US$ 4.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 12% during 2023-2028. More Info:- https://www.imarcgroup.com/gold-nanoparticles-market
The market is primarily driven by the growing prevalence of cancer across the globe. In addition, the introduction of advanced genetic engineering that helps manipulate deoxyribonucleic acid (DNA) and alter the characteristics of various organisms represents another major growth-inducing factor Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/oncology-based-in-vivo-cro-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Global Radiopharmaceutical Theragnostics Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type, Radioisotope, Source, Application, Indication, and End User,” the market is expected to grow from US$ 1,814.58 million in 2022 to US$ 3,441.97 million by 2028; it is estimated to grow at a CAGR of 11.3% from 2022 to 2028
Cardiovascular ultrasound or imaging allows healthcare professionals to monitor changes in heart structure to detect the presence of any abnormality or medical conditions such as diabetes, hypertension or other cardiovascular diseases.
Global Radiopharmaceutical Theragnostics Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type, Radioisotope, Source, Application, Indication, and End User,” the market is expected to grow from US$ 1,814.58 million in 2022 to US$ 3,441.97 million by 2028; it is estimated to grow at a CAGR of 11.3% from 2022 to 2028
The molecular imaging market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 7.51 billion by 2028 and will grow at a CAGR of 6.39% in the above mentioned forecast period.
Alzheimer’s disease therapeutics and diagnostics market is growing at a CAGR of 5.56%, and is expected to amount to $10149.5 million by 2028. Read More